H R 3 (2019)
This bill did not become law.
Last updated 2025-09-22 1:07 pm
Summary:
Directs the federal government to negotiate drug prices for Medicare directly with pharmaceutical companies and caps out-of-pocket costs for Medicare part D enrollees.
The data you see here is pulled daily from official government databases. The bill summary is created by Citizens Count staff. Learn more about our methodology for summarizing and updating bills. Visit the official government website for a deep-dive on this bill.
Browse related articles and bills:
